Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-033915)

Filing Details

Accession Number:: 0001181431-10-033915
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-18 13:00:00
Reporting Period:: 2010-06-16

Filing Date:: 2010-06-18
Accepted Time:: 2010-06-18 16:10:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1459450	Myriad Pharmaceuticals Inc.	MYRX	Pharmaceutical Preparations (2834)	263996918

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1465779	Andrew Gibbs	C/O Myriad Pharmaceuticals, Inc. 305 Chipeta Way Salt Lake City UT 84108	Vice President, Legal	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-06-16	1,153	$3.78	7,847	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2010, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on July 1, 2009.